Skip to main content
Top
Published in: Neurological Sciences 12/2021

01-12-2021 | Huntington's Disease | Original Article

Geographic differences in the incidence of Huntington’s disease in Sardinia, Italy

Authors: Antonella Muroni, Maria R. Murru, Lucia Ulgheri, Margherita Sechi, Tommaso Ercoli, Francesco Marrosu, Cesa L. Scaglione, Anna Rita Bentivoglio, Martina Petracca, Paola Soliveri, Eleonora Cocco, Stefania Cuccu, Marcello Deriu, Chiara Zuccato, Giovanni Defazio

Published in: Neurological Sciences | Issue 12/2021

Login to get access

Abstract

Background

The frequency of Huntington’s disease (HD) may vary considerably, with higher estimates in non-Asian populations. We have recently examined the prevalence of HD in the southern part of Sardinia, a large Italian Mediterranean island that is considered a genetic isolate. We observed regional microgeographic differences in the prevalence of HD across the study area similar to those recently reported in other studies conducted in European countries. To explore the basis for this variability, we undertook a study of the incidence of HD in Sardinia over a 10-year period, 2009 to 2018.

Methods

Our research was conducted in the 5 administrative areas of Sardinia island. Case patients were ascertained through multiple sources in Sardinia and Italy.

Results

During the incidence period 53 individuals were diagnosed with clinically manifested HD. The average annual incidence rate 2009–2018 was 2.92 per 106 persons-year (95% CI, 2.2 to 3.9). The highest incidence rate was observed in South Sardinia (6.3; 95% CI, 4.2–9.5). This rate was significantly higher (p<0.01) than the rates from Cagliari, Oristano, and Sassari provinces but did not significantly differ (p = 0.38) from the Nuoro rate.

Conclusions

The overall incidence of HD in Sardinia is close to the correspondent estimates in Mediterranean countries. Our findings highlight also the possibility of local microgeographic variations in the epidemiology of HD that might reflect several factors, including a possible founder effect in the rural areas of South Sardinia and Nuoro.
Literature
1.
go back to reference Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Rev Dis Primers 1:15005CrossRef Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Rev Dis Primers 1:15005CrossRef
2.
go back to reference Quarrell O, O'Donovan KL, Bandmann O, Strong M (2012) The prevalence of juvenile Huntington’s disease: a review of the literature and meta-analysis. PLoS Curr 4:e4f8606b742ef3CrossRef Quarrell O, O'Donovan KL, Bandmann O, Strong M (2012) The prevalence of juvenile Huntington’s disease: a review of the literature and meta-analysis. PLoS Curr 4:e4f8606b742ef3CrossRef
3.
go back to reference Chaganti SS, McCusker EA, Loy CT (2017) What do we know about Late Onset Huntington’s Disease? J Huntingtons Dis 6:95–103CrossRef Chaganti SS, McCusker EA, Loy CT (2017) What do we know about Late Onset Huntington’s Disease? J Huntingtons Dis 6:95–103CrossRef
4.
go back to reference Capiluppi E, Romano L, Rebora P, Nanetti L, Castaldo A, Gellera C, Mariotti C, Macerollo A, Cislaghi MG (2020) Late-onset Huntington’s disease with 40-42 CAG expansion. Neurol Sci 41:869–876CrossRef Capiluppi E, Romano L, Rebora P, Nanetti L, Castaldo A, Gellera C, Mariotti C, Macerollo A, Cislaghi MG (2020) Late-onset Huntington’s disease with 40-42 CAG expansion. Neurol Sci 41:869–876CrossRef
5.
go back to reference Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, Smeeth L (2016) The prevalence of Huntington’s disease. Neuroepidemiology. 46(2):144–153CrossRef Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, Smeeth L (2016) The prevalence of Huntington’s disease. Neuroepidemiology. 46(2):144–153CrossRef
6.
go back to reference Wexler NS, Collett L, Wexler AR, Rawlins MD, Tabrizi SJ, Douglas I, Smeeth L, Evans SJ (2016) Incidence of adult Huntington’s disease in the UK: a UK-based primary care study and a systematic review. BMJ Open 6:e009070CrossRef Wexler NS, Collett L, Wexler AR, Rawlins MD, Tabrizi SJ, Douglas I, Smeeth L, Evans SJ (2016) Incidence of adult Huntington’s disease in the UK: a UK-based primary care study and a systematic review. BMJ Open 6:e009070CrossRef
7.
go back to reference Ramos-Arroyo MA, Moreno S, Valiente A (2005) Incidence and mutation rates of Huntington’s disease in Spain: experience of 9 years of direct genetic testing. J Neurol Neurosurg Psychiatry 76:337–342CrossRef Ramos-Arroyo MA, Moreno S, Valiente A (2005) Incidence and mutation rates of Huntington’s disease in Spain: experience of 9 years of direct genetic testing. J Neurol Neurosurg Psychiatry 76:337–342CrossRef
8.
go back to reference Panas M, Karadima G, Vassos E et al (2011) Huntington’s disease in Greece: the experience of 14 years. Clin Genet 80:586–590CrossRef Panas M, Karadima G, Vassos E et al (2011) Huntington’s disease in Greece: the experience of 14 years. Clin Genet 80:586–590CrossRef
9.
go back to reference Carrassi E, Pugliatti M, Govoni V, Sensi M, Casetta I, Granieri E (2017) Epidemiological study of Huntington’s disease in the province of Ferrara, Italy. Neuroepidemiology. 49:18–23CrossRef Carrassi E, Pugliatti M, Govoni V, Sensi M, Casetta I, Granieri E (2017) Epidemiological study of Huntington’s disease in the province of Ferrara, Italy. Neuroepidemiology. 49:18–23CrossRef
10.
go back to reference Cavalli-Sforza LL, Piazza A (1993) Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet 1:3–18CrossRef Cavalli-Sforza LL, Piazza A (1993) Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet 1:3–18CrossRef
11.
go back to reference Muroni A, Murru MR, Sechi M, Ercoli T, Marrosu F, Bentivoglio AR, Petracca M, Maria Scaglione CL, Soliveri P, Cocco E, Pedron M, Murgia M, Deriu M, Cuccu S, Ulgheri L, Zuccato C, Defazio G (2020) Prevalence of Huntington’s disease in Southern Sardinia, Italy. Parkinsonism Relat Disord 80:54–57CrossRef Muroni A, Murru MR, Sechi M, Ercoli T, Marrosu F, Bentivoglio AR, Petracca M, Maria Scaglione CL, Soliveri P, Cocco E, Pedron M, Murgia M, Deriu M, Cuccu S, Ulgheri L, Zuccato C, Defazio G (2020) Prevalence of Huntington’s disease in Southern Sardinia, Italy. Parkinsonism Relat Disord 80:54–57CrossRef
12.
go back to reference Sipilä JO, Hietala M, Siitonen A, Päivärinta M, Majamaa K (2015) Epidemiology of Huntington's disease in Finland. Parkinsonism Relat Disord 21:46–49CrossRef Sipilä JO, Hietala M, Siitonen A, Päivärinta M, Majamaa K (2015) Epidemiology of Huntington's disease in Finland. Parkinsonism Relat Disord 21:46–49CrossRef
13.
go back to reference Roos AK (2017) iklund L, Laurell K. Discrepancy in prevalence of Huntington’s disease in two Swedish regions. Acta Neurol Scand 136:511–515CrossRef Roos AK (2017) iklund L, Laurell K. Discrepancy in prevalence of Huntington’s disease in two Swedish regions. Acta Neurol Scand 136:511–515CrossRef
15.
go back to reference Sahai H, Khurshid A (1996) Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. Stat Med 15(1):1–21CrossRef Sahai H, Khurshid A (1996) Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. Stat Med 15(1):1–21CrossRef
16.
go back to reference Warby SC, Visscher H, Collins JA, Doty CN, Carter C, Butland SL, Hayden AR, Kanazawa I, Ross CJ, Hayden MR (2011) HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet 19:561–566CrossRef Warby SC, Visscher H, Collins JA, Doty CN, Carter C, Butland SL, Hayden AR, Kanazawa I, Ross CJ, Hayden MR (2011) HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet 19:561–566CrossRef
17.
go back to reference Ylönen S, Sipilä JOT, Hietala M, Majamaa K (2019) HTT haplogroups in Finnish patients with Huntington disease. Neurol Genet 5:e334CrossRef Ylönen S, Sipilä JOT, Hietala M, Majamaa K (2019) HTT haplogroups in Finnish patients with Huntington disease. Neurol Genet 5:e334CrossRef
18.
go back to reference Bruzelius E, Scarpa J, Zhao Y, Basu S, Faghmous JH, Baum A (2019) Huntington’s disease in the United States: variation by demographic and socioeconomic factors. Mov Disord 34:858–865CrossRef Bruzelius E, Scarpa J, Zhao Y, Basu S, Faghmous JH, Baum A (2019) Huntington’s disease in the United States: variation by demographic and socioeconomic factors. Mov Disord 34:858–865CrossRef
19.
go back to reference Marder JA, Gu Y, Eberly S et al (2013) Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol 70:1382–1388PubMedPubMedCentral Marder JA, Gu Y, Eberly S et al (2013) Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol 70:1382–1388PubMedPubMedCentral
20.
go back to reference Falush D, Almqvist EW, Brinkmann RR et al (2001) Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am J Hum Genet 68:373–385CrossRef Falush D, Almqvist EW, Brinkmann RR et al (2001) Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am J Hum Genet 68:373–385CrossRef
21.
go back to reference Christodoulou CC, Demetriou CA, Zamba-Papanicolaou E (2020) Dietary intake, Mediterranean diet adherence and caloric intake in Huntington’s disease: a review. Nutrients 12:2946–2971CrossRef Christodoulou CC, Demetriou CA, Zamba-Papanicolaou E (2020) Dietary intake, Mediterranean diet adherence and caloric intake in Huntington’s disease: a review. Nutrients 12:2946–2971CrossRef
Metadata
Title
Geographic differences in the incidence of Huntington’s disease in Sardinia, Italy
Authors
Antonella Muroni
Maria R. Murru
Lucia Ulgheri
Margherita Sechi
Tommaso Ercoli
Francesco Marrosu
Cesa L. Scaglione
Anna Rita Bentivoglio
Martina Petracca
Paola Soliveri
Eleonora Cocco
Stefania Cuccu
Marcello Deriu
Chiara Zuccato
Giovanni Defazio
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 12/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-021-05217-y

Other articles of this Issue 12/2021

Neurological Sciences 12/2021 Go to the issue